{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:08:57Z","timestamp":1761919737122},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0076455","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T03:12:20Z","timestamp":1381547540000},"page":"e76455","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Mawar","family":"Karsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Dalla Pozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola C.","family":"Venn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie E.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita Y.","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamira","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Catchpoole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray D.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"ref1","first-page":"1164","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"CH Pui","year":"2012","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/leu.2009.268","article-title":"Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18\u201320 September 2008","volume":"24","author":"M Bruggemann","year":"2010","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/leu.2008.5","article-title":"Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia","volume":"22","author":"T Flohr","year":"2008","journal-title":"Leukemia"},{"key":"ref4","unstructured":"Marshall GM, Dalla-Pozza L, Sutton R, Ng A, de Groot-Krusemant HA, <etal>et al<\/etal>. (2013) High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. pp. doi:10.1038\/leu.2013.1044."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"V Conter","year":"2010","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1200\/JCO.2008.20.8934","article-title":"Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow","volume":"27","author":"G Basso","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2002-01-0006","article-title":"Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia","volume":"100","author":"E Coustan-Smith","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/pbc.24299","article-title":"Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR\/ABL-negative acute lymphoblastic leukemia","volume":"60","author":"J Volejnikova","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia","volume":"95","author":"ER Panzer-Grumayer","year":"2000","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2141.2009.07744.x","article-title":"Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia","volume":"146","author":"R Sutton","year":"2009","journal-title":"British Journal of Haematology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"C-H Pui","year":"2012","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"M Schrappe","year":"2011","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/leu.2008.121","article-title":"Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-[kappa] and heavy-chain gene rearrangements","volume":"22","author":"R Sutton","year":"2008","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"VHJ van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/leu.2008.324","article-title":"Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction","volume":"23","author":"R Ratei","year":"2008","journal-title":"Leukemia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"MH Zweig","year":"1993","journal-title":"Clinical Chemistry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1200\/JCO.2003.10.080","article-title":"Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia","volume":"21","author":"GM Marshall","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","article-title":"Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review","volume":"80","author":"PS Gaynon","year":"1997","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3324\/haematol.2011.047613","article-title":"Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia","volume":"97","author":"M Lauten","year":"2012","journal-title":"Haematologica"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0076455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T21:48:13Z","timestamp":1596664093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0076455"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Menendez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0076455","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}